New England Research & Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,650
| Closed | -$858K | – | 157 |
|
|
2024
Q3 | $858K | Sell |
1,650
-50
| -3% | -$26K | 0.4% | 79 |
|
|
2024
Q2 | $921K | Sell |
1,700
-325
| -16% | -$176K | 0.44% | 75 |
|
|
2024
Q1 | $1.05M | Buy |
2,025
+125
| +7% | +$64.8K | 0.52% | 65 |
|
|
2023
Q4 | $896K | Sell |
1,900
-35
| -2% | -$16.5K | 0.47% | 77 |
|
|
2023
Q3 | $843K | Sell |
1,935
-1,190
| -38% | -$518K | 0.48% | 73 |
|
|
2023
Q2 | $1.39M | Sell |
3,125
-365
| -10% | -$162K | 0.81% | 47 |
|
|
2023
Q1 | $1.61M | Sell |
3,490
-710
| -17% | -$327K | 0.94% | 31 |
|
|
2022
Q4 | $2.15M | Sell |
4,200
-1,240
| -23% | -$636K | 1.24% | 22 |
|
|
2022
Q3 | $2.47M | Buy |
5,440
+925
| +20% | +$420K | 1.56% | 17 |
|
|
2022
Q2 | $2.18M | Buy |
4,515
+1,275
| +39% | +$615K | 1.27% | 23 |
|
|
2022
Q1 | $1.59M | Hold |
3,240
| – | – | 0.83% | 42 |
|
|
2021
Q4 | $1.5M | Hold |
3,240
| – | – | 0.73% | 45 |
|
|
2021
Q3 | $1.21M | Hold |
3,240
| – | – | 0.63% | 54 |
|
|
2021
Q2 | $1.24M | Sell |
3,240
-1,200
| -27% | -$458K | 0.64% | 56 |
|
|
2021
Q1 | $1.59M | Buy |
+4,440
| New | +$1.59M | 0.87% | 39 |
|
|
2016
Q3 | – | Sell |
-5,450
| Closed | -$716K | – | 170 |
|
|
2016
Q2 | $716K | Sell |
5,450
-50
| -0.9% | -$6.57K | 0.62% | 49 |
|
|
2016
Q1 | $764K | Hold |
5,500
| – | – | 0.65% | 52 |
|
|
2015
Q4 | $767K | Buy |
5,500
+2,700
| +96% | +$377K | 0.66% | 53 |
|
|
2015
Q3 | $392K | Buy |
+2,800
| New | +$392K | 0.37% | 98 |
|